Abstract
Intravesical BCG is the reference adjuvant therapy for superficial urothelial tumours. Its adverse effects and the modalities of follow-up are now clearly established. We treated a female patient by antegrade BCG instillation for a carcinoma in situ discovered in a ureteric stump following cystectomy for generalised CIS. Treatment was well tolerated and no recurrence was observed with a follow-up of 3 years.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Administration, Intravesical
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
BCG Vaccine / administration & dosage
-
BCG Vaccine / therapeutic use*
-
Carcinoma in Situ / diagnosis
-
Carcinoma in Situ / therapy*
-
Combined Modality Therapy
-
Cystectomy*
-
Female
-
Follow-Up Studies
-
Humans
-
Middle Aged
-
Neoplasm Recurrence, Local / diagnosis
-
Neoplasm Recurrence, Local / therapy*
-
Neoplasm Staging
-
Nephrostomy, Percutaneous
-
Ureteral Neoplasms / diagnosis
-
Ureteral Neoplasms / therapy*